Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences in vascular response between primary and transplanted tumours.

S B Field1, S Needham, I A Burney

  • 1MRC Cyclotron Unit, Hammersmith Hospital, London, UK.

British Journal of Cancer
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case of Perforation of the Stomach.

The London medical and physical journal·2018
Same author

Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.

Journal of neurology, neurosurgery, and psychiatry·2017
Same author

Classification of brain tumours from MR spectra: the INTERPRET collaboration and its outcomes.

NMR in biomedicine·2016
Same author

Fracturing across the multi-scales of diverse materials.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2015
Same author

Dichloroacetate induces autophagy in colorectal cancer cells and tumours.

British journal of cancer·2014
Same author

Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo.

British journal of cancer·2014
Same journal

Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status.

British journal of cancer·2026
Same journal

Oligometastatic neuroendocrine tumors: characteristics and prognosis.

British journal of cancer·2026
Same journal

The concept of functional cure in advanced/metastatic melanoma treated with combined nivolumab and ipilimumab or nivolumab alone.

British journal of cancer·2026
Same journal

Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trial.

British journal of cancer·2026
Same journal

Altretamine induces ferroptosis in small cell lung cancer by promoting epigenetic silencing and lysosomal degradation of GPX4.

British journal of cancer·2026
Same journal

Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies.

British journal of cancer·2026
See all related articles

Tumour vascular response to hydralazine differs significantly between primary and transplanted tumors. Transplanted tumors show a much higher response rate, suggesting transplantation artifacts may influence tumor vascularity.

Area of Science:

  • Oncology
  • Vascular Biology
  • Medical Imaging

Background:

  • Most tumor vasculature studies use transplanted tumors in rodents.
  • Primary and transplanted tumors may exhibit distinct vascular characteristics.
  • Understanding these differences is crucial for accurate preclinical research.

Purpose of the Study:

  • To investigate if the vascular response to hydralazine is consistent between primary tumors and tumors derived from them via transplantation.
  • To determine the impact of tumor transplantation on vascular reactivity.

Main Methods:

  • Induction of primary tumors in mice via local irradiation.
  • Administration of hydralazine (5 mg kg-1, intraperitoneal) to assess vascular response.
  • Monitoring metabolic changes indicative of perfusion using 31P Magnetic Resonance Spectroscopy (31P MRS).

Related Experiment Videos

  • Histological comparison of primary and transplanted tumors.
  • Main Results:

    • Only 36% (4/11) of primary tumors responded to hydralazine.
    • Tumors derived from a non-responding primary tumor showed a significantly higher response rate of 94% (16/17).
    • The difference in response rates between primary and transplanted tumors was statistically significant (P = 0.001).

    Conclusions:

    • Tumor transplantation significantly alters the vascular response to hydralazine compared to primary tumors.
    • The observed discrepancy suggests that transplantation artifacts may be a primary driver of altered tumor vascularity.
    • Further research is needed to elucidate the specific mechanisms underlying this transplantation-induced artifact.